15/03/31 21:58:33.70 HhDWr1IN.net
>>115の続き
There is, of course, an offset in the form of an increased incentive
to create knowledge, which is why we have patents and copyright
in the first place. But do we really think that inadequate incentive
to create new drugs or new movies is a major problem right now?
You might try to argue that there is a US interest in enhancing
IP protection even if it’s not good for the world, because in many cases
it’s US corporations with the property rights. But are they really
US firms in any meaningful sense? If pharma gets to charge more
for drugs in developing countries, do the benefits flow back to US workers?
Probably not so much.
Which brings me to my last point: Why, exactly, should the Obama
administration spend any political capital --- alienating labor,
disillusioning progressive activists --- over such a deal?